User menu

A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment.

Bibliographic reference Knutson, F ; Osselaer, Jean-Claude ; Pierelli, L ; Lozano, M ; Cid, J ; et. al. A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment.. In: Vox Sanguinis : international journal of transfusion medicine, Vol. 109, no. 4, p. 343-352 (2015)
Permanent URL http://hdl.handle.net/2078.1/174850
  1. van Rhenen D., Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial, 10.1182/blood-2002-03-0932
  2. McCullough J., Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial, 10.1182/blood-2003-12-4443
  3. Janetzko Karin, Cazenave Jean-Pierre, Kluter Harald, Kientz Daniel, Michel Martine, Beris Photis, Lioure Bruno, Hastka Jan, Marblie Stephane, Mayaudon Veronique, Lin Lily, Lin Jin-Sying, Conlan Maureen G., Flament Jocelyne, Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set, 10.1111/j.1537-2995.2005.00550.x
  4. http://www.who.int/bloodsafety/haemovigilance/en/
  5. de Vries R. R. P., Faber J.-C., Strengers P. F. W., , Haemovigilance: an effective tool for improving transfusion practice : Haemovigilance, 10.1111/j.1423-0410.2010.01442.x
  6. Faber Jean-Claude, Work of the European Haemovigilance Network (EHN), 10.1016/j.tracli.2003.11.001
  7. Faber J.C, Haemovigilance in Europe: the European haemovigilance network, 10.1016/s1246-7820(01)00116-1
  8. Andreu Georges, Morel Pascal, Forestier Francois, Debeir Joelle, Rebibo Danielle, Janvier Gerard, Herve Patrick, Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998, 10.1046/j.1537-2995.2002.00202.x
  9. Osselaer J. C., Cazenave J. P., Lambermont M., Garraud O., Hidajat M., Barbolla L., Tardivel R., Defoin L., Waller C., Mendel I., Raidot J. P., Kandel G., De Meuter R., Fabrigli P., Dehenau D., Arroyo J. L., Padrón F., Gouezec H., Corral M., Jacquet M., Sundin D., Lin L., Corash L., An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment, 10.1111/j.1423-0410.2007.01035.x
  10. Osselaer Jean C., Messe Nathalie, Hervig Tor, Bueno Jose, Castro Emma, Espinosa Aurora, Accorsi Patrizia, Junge Klaus, Jacquet Michele, Flament Jocelyne, Corash Laurence, A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment, 10.1111/j.1537-2995.2008.01643.x
  11. Willaert Béatrice, Mai Mai-Phuong Vo, Caldani Cyril, French Haemovigilance Data on Platelet Transfusion, 10.1159/000118887
  12. Corash L., Lin J. S., Sherman C. D., Eiden J., Determination of acute lung injury after repeated platelet transfusions, 10.1182/blood-2010-06-293399
  13. Agence Francaise de Securite Sanitaire des Produits de Sante Rapport Annuel hemovigilance 2001 Paris Agence Francaise de Securite Sanitaire des Produits de Sante 2001
  14. Grass, Blood, 93, 3140 (1999)
  15. Domen, Arch Pathol Lab Med, 127, 316 (2003)
  16. Enright Helen, Davis Kathryn, Gernsheimer Terry, McCullough Jeffrey J., Woodson Robert, Slichter Sherrill J., Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial, 10.1046/j.1537-2995.2003.00529.x
  17. Agence Francaise de Securite Sanitaire des Produits de Sante Rapport Annuel Hemovigilance 2009 Paris Agence Francaise de Securite Sanitaire des Produits de Sante 2009
  18. Agence Francaise de Securite Sanitaire des Produits de Sante Rapport Annuel Hemovigilance 2010 Paris Agence Francaise de Securite Sanitaire des Produits de Sante 2010
  19. Agence Nationale de Securite du Medicament et des Produits de Sante 2011 Rapport Annuel Hemovigilance 2011 Paris Agence Nationale de Securite du Medicament et des Produits de Sante 2011
  20. Agence Nationale de Securite du Medicament et des Produits de Sante Rapport Annuel Hemovigilance 2012 Paris Agence Nationale de Securite du Medicament et des Produits de Sante 2012
  21. Swissmedic Haemovigilance Annual Report 2010 2010
  22. Swissmedic Haemovigilance Annual Report 2012 2012
  23. Swissmedic Haemovigilance Annual Report 2013 2013
  24. Cazenave Jean-Pierre, Waller Chantal, Kientz Daniel, Mendel Isabelle, Lin Lily, Jacquet Michele, Propst Meisa, Liu Weiqun, Corash Laurence, Sundin David, Defoin Laurence, Messe Nathalie, Osselaer Jean-Claude, An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment : HEMOVIGILANCE OF PCT PLASMA, 10.1111/j.1537-2995.2009.02579.x
  25. Swissmedic Haemovigilance Annual Report 2008 2008
  26. Cazenave Jean-Pierre, Isola Hervé, Waller Chantal, Mendel Isabelle, Kientz Daniel, Laforêt Michel, Raidot Jean-Pierre, Kandel Gérard, Wiesel Marie-Louise, Corash Laurence, Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period : ROUTINE USE OF PATHOGEN-INACTIVATED PLT COMPONENTS, 10.1111/j.1537-2995.2010.02873.x
  27. Tobian Aaron A.R., Fuller Alice K., Uglik Kristin, Tisch Daniel J., Borge Prabhakar D., Benjamin Richard J., Ness Paul M., King Karen E., The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME) : PAS, Allergic Reactions, and Increments, 10.1111/trf.12498